Literature DB >> 31788927

One repressor to rule them all: ANCO1 links YAP and AIB1.

Can Zhang1, Kenneth Moberg1.   

Abstract

The transcriptional co-activators YAP and AIB1 individually promote breast cancer progression, but are not known to be mechanistically linked. A study published in this issue of EMBO Reports [1] now shows that YAP-AIB1 form a physical complex in breast epithelial cells that cooperates in both activation and, unexpectedly, repression of key breast cancer genes. The repressive effect is due to the recruitment of ANCO1, a previously defined AIB1 interactor [2] that binds and inhibits the YAP-AIB1 complex. These data identify ANCO1 as a candidate tumor suppressor through YAP-AIB1 inhibition and could hint at a broader crosstalk between pathways that utilize YAP and AIB1 to control epithelial homeostasis.
© 2019 The Authors.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31788927      PMCID: PMC6944913          DOI: 10.15252/embr.201949647

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  10 in total

1.  Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.

Authors:  Aihua Zhang; Percy Luk Yeung; Chia-Wei Li; Shih-Chieh Tsai; Gia Khanh Dinh; Xiaoyang Wu; Hui Li; J Don Chen
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  The ecdysone receptor coactivator Taiman links Yorkie to transcriptional control of germline stem cell factors in somatic tissue.

Authors:  Can Zhang; Brian S Robinson; Wenjian Xu; Liu Yang; Bing Yao; Heya Zhao; Phil K Byun; Peng Jin; Alexey Veraksa; Kenneth H Moberg
Journal:  Dev Cell       Date:  2015-07-02       Impact factor: 12.270

4.  Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.

Authors:  Jason P Garee; Christopher D Chien; Jordan V Li; Anton Wellstein; Anna T Riegel
Journal:  Mol Endocrinol       Date:  2014-03-28

5.  Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

Authors:  H J List; R Reiter; B Singh; A Wellstein; A T Riegel
Journal:  Breast Cancer Res Treat       Date:  2001-07       Impact factor: 4.872

Review 6.  The Hippo Signaling Pathway in Development and Disease.

Authors:  Yonggang Zheng; Duojia Pan
Journal:  Dev Cell       Date:  2019-08-05       Impact factor: 12.270

7.  Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.

Authors:  Jian Yuan Goh; Min Feng; Wenyu Wang; Gokce Oguz; Siti Maryam J M Yatim; Puay Leng Lee; Yi Bao; Tse Hui Lim; Panpan Wang; Wai Leong Tam; Annette R Kodahl; Maria B Lyng; Suman Sarma; Selena Y Lin; Alexander Lezhava; Yoon Sim Yap; Alvin S T Lim; Dave S B Hoon; Henrik J Ditzel; Soo Chin Lee; Ern Yu Tan; Qiang Yu
Journal:  Nat Med       Date:  2017-09-25       Impact factor: 53.440

8.  A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.

Authors:  Chi Zhu; Li Li; Zhao Zhang; Mingjun Bi; Hu Wang; Wenyue Su; Karen Hernandez; Pingping Liu; Junqiang Chen; Mingqiu Chen; Tim Hui-Ming Huang; Lizhen Chen; Zhijie Liu
Journal:  Mol Cell       Date:  2019-07-11       Impact factor: 17.970

Review 9.  KBG syndrome.

Authors:  Dayna Morel Swols; Joseph Foster; Mustafa Tekin
Journal:  Orphanet J Rare Dis       Date:  2017-12-19       Impact factor: 4.123

10.  Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.

Authors:  Max H Kushner; Virginie Ory; Garrett T Graham; Ghada M Sharif; William B Kietzman; Sophia Thevissen; Meng Yuan; Marcel O Schmidt; Anton Wellstein; Anna T Riegel
Journal:  EMBO Rep       Date:  2019-12-02       Impact factor: 8.807

  10 in total
  1 in total

Review 1.  SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.

Authors:  Licen Li; Chu-Xia Deng; Qiang Chen
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.